S&P sets new record with coronavirus stimulus, vaccine in focus

S&P sets new record with coronavirus stimulus, vaccine in focus



U.S. equity markets opened in record territory as traders weighed a setback in COVID-19 relief talks and the pending approval of a vaccine.